Skip to content

DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.

DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01731132
Acronym
DIUQoL
Enrollment
207
Registered
2012-11-21
Start date
2012-07-31
Completion date
2014-07-31
Last updated
2015-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

HRQoL, IUD, Contraception, SEC-QoL

Brief summary

Knowledge about the impact on quality of life of women initiating IUD in the Spanish population at baseline and after 12 months of use.

Interventions

DRUGLevonorgestrel IUD or Copper IUD

Women who initiate the use of an IUD at the time of the study.

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* 18-49 years old female. * Women who is visited by a gynecology or primary care physician and starts contraception with an IUD/IUS. * Women that has not used hormonal contraception in any form in the last 3 months. * Women who have no problems listening, reading or writing. * Women who gives their written consent to participate in the study.

Exclusion criteria

* Women who have contraindications to use IUDs. * Women with previous experience with IUDs. * Women who initiates the use of IUDs for other purposes other than contraception. * Woman who is participating in a clinical trial at the time of initiating the study.

Design outcomes

Primary

MeasureTime frame
Impact on quality of life of women initiating IUD in a Spanish population assessed by questionnaire.After 12 months

Secondary

MeasureTime frame
Demographic Data (Age, Place of Birth, Level of Education, Employment status, Personal marital situation, etc.) assessed by questionnaire.Baseline

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026